| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,793 | 14,255 | 15,142 | 15,074 | | Cost of Revenue | 2,448 | 2,694 | 3,431 | 3,942 | | | Gross Profit | 11,345 | 11,561 | 11,711 | 11,132 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,239 | 7,958 | 7,456 | 6,365 | | Non Recurring | (258) | 258 |
-
|
-
| | Others | 3,687 | 2,380 | 4,521 | 1,742 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 677 | 965 | (266) | 3,025 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 677 | 965 | (266) | 3,025 | | Interest Expense | 436 | 520 | 665 | 859 | | Income Before Tax | 241 | 445 | (931) | 2,166 | | Income Tax Expense | 39 | 102 | (211) | 691 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 202 | 343 | (720) | 1,475 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 202 | 343 | (720) | 1,475 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $202 | $343 | ($720) | $1,475 |
|
0.46% Nasdaq 
Income Statement
